114 related articles for article (PubMed ID: 36596519)
21. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
Cassimere EK; Pyndiah S; Sakamuro D
Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1.
Spender LC; Inman GJ
J Biol Chem; 2009 Jan; 284(3):1435-42. PubMed ID: 19022773
[TBL] [Abstract][Full Text] [Related]
23. ARF differentially modulates apoptosis induced by E2F1 and Myc.
Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
[TBL] [Abstract][Full Text] [Related]
25. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors.
Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S
Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262
[TBL] [Abstract][Full Text] [Related]
26. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states.
Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T
Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437
[TBL] [Abstract][Full Text] [Related]
27. The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1.
Qiao L; Zhang Q; Zhang W; Chen JJ
J Cell Mol Med; 2018 Nov; 22(11):5333-5345. PubMed ID: 30079588
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
29. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
30. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T
Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
[TBL] [Abstract][Full Text] [Related]
32. Ascochlorin, an isoprenoid antibiotic, induces G1 arrest via downregulation of c-Myc in a p53-independent manner.
Jeong JH; Chang YC
Biochem Biophys Res Commun; 2010 Jul; 398(1):68-73. PubMed ID: 20558137
[TBL] [Abstract][Full Text] [Related]
33. Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanisms.
Shi X; Mihaylova VT; Kuruvilla L; Chen F; Viviano S; Baldassarre M; Sperandio D; Martinez R; Yue P; Bates JG; Breckenridge DG; Schlessinger J; Turk BE; Calderwood DA
Proc Natl Acad Sci U S A; 2016 Aug; 113(31):E4558-66. PubMed ID: 27432991
[TBL] [Abstract][Full Text] [Related]
34. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Hahm ER; Singh SV
Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
[TBL] [Abstract][Full Text] [Related]
35. Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
Graves TG; Harr MW; Crawford EL; Willey JC
Mol Cancer; 2006 Jan; 5():1. PubMed ID: 16403226
[TBL] [Abstract][Full Text] [Related]
36. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
37. Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth.
Duan N; Hu X; Qiu H; Zhou R; Li Y; Lu W; Zhu Y; Shen S; Wu W; Yang F; Liu N
Cell Death Dis; 2023 Dec; 14(12):801. PubMed ID: 38062013
[TBL] [Abstract][Full Text] [Related]
38. Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer.
Enomoto K; Zhu X; Park S; Zhao L; Zhu YJ; Willingham MC; Qi J; Copland JA; Meltzer P; Cheng SY
J Clin Endocrinol Metab; 2017 Jul; 102(7):2268-2280. PubMed ID: 28368473
[TBL] [Abstract][Full Text] [Related]
39. Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription.
Walter KA; Hossain MA; Luddy C; Goel N; Reznik TE; Laterra J
Mol Cell Biol; 2002 Apr; 22(8):2703-15. PubMed ID: 11909963
[TBL] [Abstract][Full Text] [Related]
40. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
